Trimethoprim-Sulphamethoxazole Treatment in Staphylococcal Endocarditis and Gram-Negative Septicemia
- 1 June 1974
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 6 (2), 177-182
- https://doi.org/10.3109/inf.1974.6.issue-2.13
Abstract
Treatment with trimethoprim-sulphamethoxazole (co-trimoxazole) was successful in one patient with severe staphylococcal endocarditis and in one with multiresistant Escherichia coli septicemia. The case histories are reported.Keywords
This publication has 14 references indexed in Scilit:
- Present significance of resistance to trimethoprim and sulphonamides in coliforms,Staphylococcus aureus, andStreptococcus faecalisJournal of Clinical Pathology, 1973
- Azidocillin Treatment of Enterococcal SepticemiaScandinavian Journal of Infectious Diseases, 1972
- Transferable Resistance to Antibiotics in Gram-Negative Bacteria Isolated in a Hospital for Infectious Diseases: I. Occurrence and Multiple Origin of R FactorsScandinavian Journal of Infectious Diseases, 1972
- Trimethoprim Resistance determined by R FactorsBMJ, 1972
- TRIMETHOPRIM-RESISTANT COLIFORMSThe Lancet, 1972
- Q fever endocarditis treated with trimethoprim and sulphamethoxazole.BMJ, 1972
- ANTIBIOTIC RESISTANCE OF COLIFORM BACILLI IN URINARY INFECTION ACQUIRED BY WOMEN OUTSIDE HOSPITAL: A 12-year SurveyThe Lancet, 1971
- Urinary Tract Pathogens-Sensitivity to Trimethoprim/SulphamethoxazoleScandinavian Journal of Infectious Diseases, 1970
- Esch. coli endocarditis successfully treated with oral trimethoprim and sulphamethoxazole.Heart, 1970
- Trimethoprim: laboratory and clinical studiesJournal of Clinical Pathology, 1968